GlobeNewsWire
09 Jun 2026, 10:38 UTC · 1h ago
Burning Rock Reports First Quarter 2026 Financial Results
- healthcare▲33%
- earnings
- china
- BNR
- biotechnology
- financial results
- next generation sequencing
- precision oncology
Top 1 mover · tap to explore
GlobeNewsWire
09 Jun 2026, 10:38 UTC · 1h ago
Top 1 mover · tap to explore
Story key points
5 claims · impact-rated
Burning Rock Biotech's Q1 2026 revenues decreased by 18.9% year-over-year to RMB107.9 million. — A significant double-digit decline in top-line revenue suggests weakening demand or loss of market share in their core oncology testing business.
-0.70The company's net loss widened to RMB17.5 million for the first quarter of 2026, compared to RMB13.5 million in the same period last year. — Increasing net losses despite cost-cutting measures indicate a struggle to reach profitability and puts pressure on the company's valuation.
-0.50Gross margin for pharma research and development services dropped significantly from 57.5% in 2025 to 47.4% in 2026. — The decline in a key high-margin segment suggests a shift toward less profitable projects or pricing pressure.
-0.30Continue reading
6 related stories
Operating expenses were reduced by 14.0% to RMB96.9 million through business cost and payment collection controls. — Aggressive cost management provides some support to the bottom line and demonstrates operational discipline amid falling revenues.
+0.20The company holds RMB448.7 million (US$65.1 million) in cash, cash equivalents, and restricted cash as of March 31, 2026. — A healthy cash position provides a liquidity buffer to sustain operations while the company attempts to pivot or grow.
+0.20Ticker attribution
Model heads
The company reported a decrease in revenues and gross profit, alongside an increase in net loss compared to the same period last year.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
4 dimensions · 9 clusters
Market reaction
0 bid · 10 offered
No stock impact ranking available yet.
GlobeNewsWire
1h ago
